Last reviewed · How we verify

NCT04402450

Suprainguinal Fascia Iliaca Block Versus PENG Block for Hip Arthroplasty Analgesia

Completed NA Last updated 28 September 2021
What this trial tests

NA trial testing Ultrasound-guided suprainguinal fascia iliaca nerve block in Postoperative Complications in 40 participants. Completed in 28 May 2021.

Timeline
31 August 2020
Primary endpoint
25 May 2021
28 May 2021

Quick facts

Lead sponsorUniversity of Chile
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment40
Start date31 August 2020
Primary completion25 May 2021
Estimated completion28 May 2021
Sites1 location across Chile

Drugs / interventions tested

Conditions studied

Sponsor

University of Chile

Who can join

Adults 18 to 80, any sex, with Postoperative Complications or Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In recent years, suprainguinal fascia iliaca block (SFIB) has emerged as a reliable analgesic option for primary total hip arthroplasty (THA). In 2018, a new block was described, termed pericapsular nerve group block or PENG block, that selectively targets the articular branches of the femoral and obturator nerves while sparing their motor components. In this randomized trial, the investigators will compare US-guided SFIB and PENG block in patients undergoing primary THA. Since the main benefit of PENGB stems from its quadriceps-sparing effect, it was selected the incidence of quadriceps motor block (at 6 hours) as the primary outcome and the hypothesis that PENG block will result in significantly less motor block compared to SFIB.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Randomized comparison between pericapsular nerve group (PENG) block and suprainguinal fascia iliaca block for total hip arthroplasty.
    Aliste J, Layera S, Bravo D, Jara Á, et al · · 2021 · cited 129× · PMID 34290085 · DOI 10.1136/rapm-2021-102997

Verify or expand the search:

Other recruiting trials for Postoperative Complications

Currently open trials in the same condition.

Other University of Chile trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04402450.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing